fentanyl spirig hc 12 ug/h depotpflaster
spirig healthcare ag - fentanylum - depotpflaster - fentanylum 1.38 mg, dipropylenglycolum, excipiens der vorbereitung für 4,2 cm2 mit der befreiung von 12,5 µg/h. - analgetikum - synthetika
metoprolol-mepha zok 25 depotabs
mepha pharma ag - metoprololi tartras (2:1) - depotabs - metoprololi succinas (2:1) 23.75 mg corresp. metoprololi tartras (2:1) 25 mg, excipiens pro compresso obducto. - beta-rezeptorenblocker - synthetika human
metoprolol-mepha zok 50 depotabs
mepha pharma ag - metoprololi tartras (2:1) - depotabs - metoprololi succinas (2:1) 47.5 mg corresp. metoprololi tartras (2:1) 50 mg, excipiens pro compresso obducto. - beta-rezeptorenblocker - synthetika human
metoprolol-mepha zok 100 depotabs
mepha pharma ag - metoprololi tartras (2:1) - depotabs - metoprololi succinas (2:1) 95 mg corresp. metoprololi tartras (2:1) 100 mg, excipiens pro compresso obducto. - beta-rezeptorenblocker - synthetika human
metoprolol-mepha zok 200 depotabs
mepha pharma ag - metoprololi tartras (2:1) - depotabs - metoprololi succinas (2:1) 190 mg corresp. metoprololi tartras (2:1) 200 mg, excipiens pro compresso obducto. - beta-rezeptorenblocker - synthetika human
ropinirol-mepha 2 retard depotabs
mepha pharma ag - ropinirolum - depotabs - ropinirolum 2 mg zu ropiniroli hydrochloridum, excipiens pro compresso dunst. - morbus parkinson - synthetika
ropinirol-mepha 4 retard depotabs
mepha pharma ag - ropinirolum - depotabs - ropinirolum 4 mg zu ropiniroli hydrochloridum, color.: e 110, e 132, excipiens pro compresso dunst. - morbus parkinson - synthetika
ropinirol-mepha 8 retard depotabs
mepha pharma ag - ropinirolum - depotabs - ropinirolum 8 mg zu ropiniroli hydrochloridum, excipiens pro compresso dunst. - morbus parkinson - synthetika
gliclazid-mepha 60 retard depotabs
mepha pharma ag - gliclazidum - depotabs - gliclazidum 60 mg, excipiens pro compresso obducto. - orale blutzuckersenkende mittel - synthetika
abilify maintena 400 mg depot-injektionssuspension in einer fertigspritze
lundbeck (schweiz) ag - aripiprazolum - depot-injektionssuspension in einer fertigspritze - praeparatio cryodesiccata: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, ad pulverem. solvens: aqua ad iniectabile. solutio reconstituta: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium max. 2.2 mg. - neuroleptikum - synthetika